Meet the ACE TA Center: Microlearning Module
Resource updated 10/30/2023
Resource updated 10/30/2023
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Resource from the RWHAP Best Practices Compilation updated on 05/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/08/2024
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
Design of curriculum to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
Module to assess provider community's awareness and perspectives on opioid use risks among clients as a decision point on whether to undertake integration of buprenorphine use within the HIV clinic. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Review of the terminology of addiction, opioid use, and MAT, in order to enhance staff understanding of how buprenorphine treatment fits into the larger treatment picture and improve their health literacy on the subject. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Overview of addiction and medication-assisted addiction treatment, including buprenorphine and methadone. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Review of opioid addiction treatment, specifically buprenorphine, and its variance from methadone and naltrexone opioid addiction treatment options. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Review of the SPNS Buprenorphine Initiative, the reasons behind its funding, and its overall findings across grantee sites. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Review of major steps required to get going in buprenorphine certification and administration (e.g., prescribing, administration, staffing). Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Module (factsheet) quick reference guide to providers and staff on frequently asked questions and answers regarding buprenorphine treatment. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Group activity to allow clinic staff to practice patient-provider role playing, providing the instructor with an opportunity to identify any communication or cultural competency issues that may need addressing Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.